A study of aripiprazole combined with clozapine in refractory schizophrenia
Lixia Li
Abstract
Lixia Li
Abstract
Objective:To explore the efficacy and safety of aripiprazole and clozapine combination for the treatment of refractory schizophrenia.Methods:84 cases of chronic refractory schizophrenia were randomly assigned to two groups(aripirazole with clozapine or clozapine alone) for 3.months and were assessed with the brief psychiatric rating scale(BPRS).Results: aripiprazole combined with clozapine was superior to clozapine alone,mored efficacy and less side effects.Conclusions:
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the efficacy and safety of aripiprazole and clozapine combination for the treatment of refractory schizophrenia.Methods:84 cases of chronic refractory schizophrenia were randomly assigned to two groups(aripirazole with clozapine or clozapine alone) for 3.months and were assessed with the brief psychiatric rating scale(BPRS).Results: aripiprazole combined with clozapine was superior to clozapine alone,mored efficacy and less side effects.Conclusions:
Key concepts: Clozapine, Aripiprazole, Schizophrenia (object-oriented programming), Brief Psychiatric Rating Scale, Refractory (planetary science), Medicine, Psychiatry, Internal medicine